BioNexus Gene Lab
BGLC
S$5.74
Share price
-1.98%
Change (1 day)
773.35%
Change (1 year)
Categories
BioNexus Gene Lab (BGLC) - Total liabilities
Total liabilities on the balance sheet as of March 2025 : S$2.19 Million
According to BioNexus Gene Lab's latest financial reports the company's total liabilities are S$2.19 Million. A company’s total liabilities is the sum of all current and non-current debts and obligations.
BioNexus Gene Lab - Total liabilities on balance sheet (from 2019 to 2025)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2023-12-31 | S$2.3 M | -17.3% |
| 2022-12-31 | S$2.78 M | -14.07% |
| 2021-12-31 | S$3.23 M | -29.14% |
| 2020-12-31 | S$4.56 M | 3012.36% |
| 2019-12-31 | S$0.14 M | -17.55% |
| 2018-12-31 | S$0.17 M |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | S$29.76 M | 1,253.39% | 🇺🇸 USA |